ALZN Alzamend Neuro, Inc.
$1.13▼ -0.88%
Healthcare
Other
Volume 8.8K
Avg Volume (10D) 17.0K
Key Metrics & Fundamentals
Market Cap
$5.45M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.84 - 2.68
% vs 50 MA
-27.37%
% vs 200 MA
-24.28%
RSI-14
28.5
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.78
Free Cash Flow
-$1.14M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.00M
COGS
–
Operating Exp
$3.03M
Operating Income
-$3.03M
EBIT
-$3.03M
Pretax Income
-$3.03M
Net Income
-$3.03M
EPS (Diluted)
-0.68
Price & Volume History
Loading chart…
Recent News
Alzamend Neuro (ALZN) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Oct 8, 2026 11:00 AM ET
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Zacks · Sep 22, 2026 9:40 AM ET
Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
PR Newswire · Sep 16, 2026 8:00 AM ET
Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
PR Newswire · Aug 20, 2026 8:00 AM ET
Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain
PR Newswire · Aug 18, 2026 8:00 AM ET
Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending
PR Newswire · Aug 4, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ALZN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.